Conversely, research by Dai et al. in lung cancer demonstrated that USP7 inhibition might actually intensify PD-L1 expression, associated with greater infiltration of M1 macrophages and IFN-γ+CD8+ T cells, culminating in a robust anti-tumor effect [209]. The gene discussed is USP7; the disease is neoplasm.